Womens Health Diagnostics Market (By Type: Diagnostics Devices, Diagnostics Tests; By Application: Breast Cancer, Infectious Diseases Testing, Osteoporosis Testing, Pregnancy And Fertility Testing, Sexually Transmitted Diseases Testing, Other; By End-User: Hospital and Diagnostics Centers, Home Care) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Womens Health Diagnostics Market Size and Growth 2024 to 2033

The global womens health diagnostics market size was valued at USD 21.48 billion in 2023 and is anticipated to reach around USD 43.54 billion by 2033, growing at a CAGR of 7.32% from 2024 to 2033. The increasing demand for the diagnostics of women-centric health conditions drives the growth of the market.

To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics

Womens Health Diagnostics Market Key Takeaways

• The North America womens health diagnostics market size accounted for USD 9.67 billion in 2023 and is expected to attain around USD 19.81 billion by 2033, poised to grow at a CAGR of 7.43% between 2024 and 2024.
• North America led the women health diagnostics market with the largest market size in 2023.
• Asia Pacific is expected to witness the fastest growth in the market during the forecast period.
• By type, the diagnostics devices segment dominated the market with the largest share in 2023.
• By application, the breast cancer segment dominated the market with the highest share in 2023.
• By end-user, the hospital and diagnostics centers segment dominated the market in 2023.

U.S. Womens Health Diagnostics Market Size and Growth 2024 to 2033

The U.S. womens health diagnostics market size was estimated at USD 7.25 billion in 2023 and is predicted to be worth around USD 14.96 billion by 2033 with a CAGR of 7.51% from 2024 to 2033.

North America led the women health diagnostics market with the largest market size in 2023. The growth of the market in the region is increasing due to the rising number of women affected by some type of diseases due to the changing lifestyle choices, accepting sedentary lifestyle, eating and sleeping habits, higher consumption of alcohol and smoking that causes the chronic illness in the women population that is contributing in the expansion of the women’s health diagnostics centers. The increasing prevalence of women-oriented cancers like breast cancer, cervical cancer, and others is highly driving the demand for the women health diagnostics market in the region.

• For instance, the maternal mortality rate in the U.S. is three times higher than the ten other economically developed countries, including the United Kingdom, Canada, and Germany.
• Cancer is one of the second leading causes of death in the U.S.. 1 in 5 deaths occur as per the research, and 600,000 people die every year in the U.S. due to cancer. It is also projected that the cost associated with cancer diagnosis and treatment will reach $246 billion by 2030 in the U.S.

Asia Pacific is expected to witness the fastest growth during the forecast period. The growth of the market in the region is attributed to the rising women aging population and the rising prevalence of infectious diseases among women, the modern lifestyle impacting body reproductive organ issues, and the increasing chronic illnesses such as diabetes, cardiovascular diseases, and other infectious diseases in the women is driving the demand for the women health diagnostics centers. The increasing investment by the government in the development of women-centric diagnostics centers and innovative launches associated with women's diagnostics procedures are driving the growth of the women health diagnostics market in the region.

Asia Pacific Womens Health Diagnostics Market Size and Growth 2024 to 2033

The Asia Pacific womens health diagnostics market size was calculated at USD 4.73 billion in 2023 and is projected to expand around USD 9.80 billion by 2033, poised to grow at a CAGR of 7.55% from 2024 to 2033.

Womens Health Diagnostics Market Overview

The women health diagnostics market focuses on a specialized diagnostic process and center that helps to treat women-oriented health conditions. It includes the production of diagnostics kits and medications that help in the diagnosis process of various health issues associated with women. The increasing prevalence of chronic diseases such as diabetes, reproductive organ-related issues, breast cancer, cervical cancers, and other infectious diseases accelerates the demand for the market. The ongoing investment and research in medical science drive advancements in women's health diagnostics, which have also contributed to the growth of the market.

Womens Health Diagnostics Market Growth Factors

• The rising awareness about women's associated diseases due to the changing lifestyle and the increasing prevalence of infectious diseases like hepatitis, HIV, and others is driving the growth of the market.
• The rising burden of diseases women associated diseases such as ovarian, breast cancer, cervical cancer, infertility, and autoimmune diseases drives the demand for the proper diagnostics that drive the expansion of the market.
• Rising healthcare expenditures due to rising awareness about diseases drive the growth of diagnostic centers.
• The rising investment in the development of healthcare facilities in economically developed countries contributes to the expansion of the women health diagnostics market.
• Government initiatives such as increasing healthcare expenditures, funding for R&D, developing better infrastructure, and supporting and starting awareness initiatives drive market growth.

Womens Health Diagnostics Market Scope

Womens Health Diagnostics Market Dynamics

Driver: Rising prevalence of chronic diseases in women

The increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, infectious diseases, and others is accelerating the demand for specialized women’s health diagnostics centers globally. Women's health diagnostics centers work with innovative and targeted diagnostics tests to improve women's health outcomes. The rising complications in the reproductive system, heart diseases, mental health illness, sexual transmission infections, osteoarthritis, stroke, stress, and urinary tract infections in women are driving the demand for women's health diagnostics.

Heart stroke, diabetes, and heart disease are some of the common diseases that affect both men and women. Some of the diseases only affect the female organs, such as the ovaries, uterus, fallopian tubes, and vagina, and they can develop the issues like fibrosis, cysts, or cancer. The increasing prevalence of chronic diseases due to changing lifestyle habits further contributes to the growth of the women health diagnostics market.

• For instance, according to data published in the Lifestyle Medicine Journal, it is estimated that by 2030, the cost associated with chronic conditions will reach up to $47 trillion around the globe.

Restraint: Increased diagnostics cost

The higher cost of the diagnostics of several diseases limits the adoption of the women health diagnostics market. Hospitals in economically developing countries have less of a budget for the deployment of such technologically advanced health diagnostic devices due to the higher cost of the machines or devices that restrict the growth of the market. Underdeveloped countries lack resources and do not have large healthcare budgets, which is why they are only able to invest in highly essential resources. In the case of developed countries, due to inflation and the high cost of healthcare, people who belong to the poor class and people who live in rural areas are not able to afford basic resources.

Opportunity: Trends and advancements in women’s health diagnostics

The increasing investment in advancements in women's health diagnostics to improve women's health outcomes and the development of diagnostics centers are driving the opportunity for market growth. The technological integration in the diagnostic process, such as breast cancer screening, HPV, NIPT, and personalized fertility testing, enhances the early detection and treatment process. Healthcare trends like telemedicine and remote monitoring technologies in the diagnostics of diseases, especially for women in remote areas, are enhancing the health outcomes of women.

The increasing investments in the research and development activities in the innovative and more accessible, personalized, accurate diagnostics process that can fulfill the unique health requirement in women. Thus, all the technological advancements in women’s health diagnostics drive opportunities in the women health diagnostics market.

Type Insights

The diagnostics devices segment dominated the women health diagnostics market with the largest share in 2023. Diagnostic devices are used by professional physicians or doctors to detect, diagnose, and monitor medical conditions. Diagnostic devices help in treatment planning and monitoring, disease staging and prognosis, and guiding surgical interventions. Diagnostic medical imaging equipment, electrocardiograph (ECG) machines, spirometers, blood pressure monitors, endoscopes, self-diagnostic kits, and laboratory equipment are some of the diagnostics devices. The rising prevalence of diseases drives the demand for medical diagnostics devices for the treatment and monitoring of patients, which drives the demand for the segment.

• For instance, in April 2024, GE HealthCare launched Voluson Signature 18 and 20 ultrasound systems, which are enhanced by artificial intelligence for advanced health imaging in women. The systems are adaptable and have scalable software and high-performance hardware.

Application Insights

The breast cancer segment dominated the women health diagnostics market with the highest share in 2023. The growth of the segment is attributed to the rising incidence of breast cancer in women globally, which is driving the demand for women’s health diagnostics centers. Breast cancer is one of the most common types of cancer in women globally. Breast cancer is caused by abnormal growth of the cancerous cells in the breast and becomes a tumor. Approximately 80% of breast cancers are invasive, and they spread from the breast to the other part of the body.

A maximum of women above the age of 50 are likely to be affected by breast cancer. Invasive (infiltrating) ductal carcinoma (IDC), Lobular breast cancer, Ductal carcinoma in situ (DCIS), Triple-negative breast cancer (TNBC), inflammatory breast cancer (IBC), and Paget’s disease of the breast are some of the types of breast cancer. Increased alcohol consumption, genetics, family history, smoking, radiation exposure, obesity, and hormonal replacement therapy are the major cause of breast cancer in women.

• For instance, breast cancer is one of the most common cancer types found in the U.S. in 2023.  It is the second leading cause of mortality in women. There are approximately 297,790 new cases of invasive breast cancer in women. As of 2023, there are 43170 women have died due to breast cancer.
• In September 2023, a leader in AI-powered cancer diagnostic devices, Ibex Medical Analytics, launched an AI-powered device called Galen™ Breast HER2, which is capable of providing accurate and reproducible HER2 scoring for better diagnosis of breast cancer.

End-User Insights

The hospital and diagnostics centers segment projected the highest growth in the market in 2023. The rising acceptance and preferences for the treatment and diagnostics of several kinds of illnesses and disorders are driving the segment's expansion. The rising investment by the public and private institutes for the development of hospital and diagnostic centers and the higher availability of professional physicians, technologically advanced medical equipment, and devices in the hospitals and diagnostics centers drive the segment's growth.

Womens Health Diagnostics Market Recent Developments

• In May 2024, a bio-analytical-based women’s health organization, Aspira Women’s Health Inc., working on the development of gynecologic disease diagnostic tools, announced the launch of the updated OvaWatch ovarian cancer risk assessment test.
• In May 2024, Roche launched the National Women’s Checkup Week (NWCW), which is organized in Singapore for the second consecutive year for entitled women to take appropriate control and action regarding their own health.
• In May 2024, PinkDx was launched by diagnostics pioneer Bonnie Anderson to focus on women's health.
• In May 2024, five major women health-centric companies, Neura Health, Paloma Health, Seven Starling, LEVY Health, and Origin, collaborated to announce The Wonder Women Collective. The strategic collaboration will focus on working on critical gaps in women’s healthcare, promoting health equity and healthcare outcomes, enhancing women's health, and reducing costs.

Women Health Diagnostics Market Companies

• F. Hoffmann-la Roche Ltd.
• Becton, Dickinson, and Company
• Hologic, Inc.
• Siemens Aktiengesellschaft
• Abbott Laboratories
• Ge Healthcare
• Quest Diagnostics Incorporated
• Koninklijke Philips N.V.

Segments Covered in the Report

By Type

• Diagnostics Devices
• Diagnostics Tests

By Application

• Breast Cancer
• Infectious Diseases Testing
• Osteoporosis Testing
• Pregnancy And Fertility Testing
• Sexually Transmitted Diseases Testing
• Other

By End-User

• Hospital and Diagnostics Centers
• Home Care

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa